Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Evaluation of in Vitro Activity of Ceftazidime/Avibactam and Ceftolozane/Tazobactam against ESBL-producing Enterobacterales Isolated from Intensive Care Units from Qatar.

Autor: Ahmed MAS; Division of Microbiology, Department of Pathology and Laboratory Medicine, Hamad Medical Corporation, Doha, Qatar.; The Life Science Centre, School of Science and Technology, -rebro University, -rebro, Sweden., Ibrahim EB; Division of Microbiology, Department of Pathology and Laboratory Medicine, Hamad Medical Corporation, Doha, Qatar.; Biomedical Research Centre, Qatar University, Doha, Qatar., Hamid JM; Division of Microbiology, Department of Pathology and Laboratory Medicine, Hamad Medical Corporation, Doha, Qatar., Daghfal J; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar., Alyazidi MA; Division of Microbiology, Department of Pathology and Laboratory Medicine, Hamad Medical Corporation, Doha, Qatar., Abdelwahab AH; Division of Microbiology, Department of Pathology and Laboratory Medicine, Hamad Medical Corporation, Doha, Qatar., Al-Maslamani MA; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar., Al Khal AL; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar., Abdel Hadi H; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.

Publikováno v: Oman medical journal [Oman Med J] 2022 Sep 30; Vol. 37 (5), pp. e422. Date of Electronic Publication: 2022 Sep 30 (Print Publication: 2022).

Association of bla VIM-2 , bla PDC-35 , bla OXA-10,   bla OXA-488 and bla VEB-9 β-Lactamase Genes with Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam in Multidrug-Resistant Pseudomonas aeruginosa .

Autor: Sid Ahmed MA; Department of Laboratory Medicine and Pathology, Microbiology Division, Hamad Medical Corporation, Doha 3050, Qatar.; The Life Science Centre-Biology, School of Science and Technology, Orebro University, 701 82 Örebro, Sweden., Khan FA; The Life Science Centre-Biology, School of Science and Technology, Orebro University, 701 82 Örebro, Sweden., Hadi HA; Communicable Diseases Center, Hamad Medical Corporation, Doha 3050, Qatar.; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha 3050, Qatar., Skariah S; Department of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Doha 2713, Qatar., Sultan AA; Department of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Doha 2713, Qatar., Salam A; Department of Epidemiology and Biostatistics, King Fahad Specialist Hospital, Dammam 31444, Saudi Arabia., Al Khal AL; Communicable Diseases Center, Hamad Medical Corporation, Doha 3050, Qatar.; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha 3050, Qatar., Söderquist B; School of Medical Sciences, Faculty of Medicine and Health, Orebro University, 701 82 Örebro, Sweden., Ibrahim EB; Department of Laboratory Medicine and Pathology, Microbiology Division, Hamad Medical Corporation, Doha 3050, Qatar.; Department of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Doha 2713, Qatar., Omrani AS; Communicable Diseases Center, Hamad Medical Corporation, Doha 3050, Qatar.; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha 3050, Qatar., Jass J; The Life Science Centre-Biology, School of Science and Technology, Orebro University, 701 82 Örebro, Sweden.

Publikováno v: Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2022 Jan 19; Vol. 11 (2). Date of Electronic Publication: 2022 Jan 19.

Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population.

Autor: Cyprian FS; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar.; Department of Basic Medical Sciences, College of Medicine, Member of QU Health, Qatar University, Doha, Qatar., Suleman M; Institute of Microbiology, University of Veterinary and Animal Sciences, Lahore, Pakistan., Abdelhafez I; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar., Doudin A; Department of Math and Science, Community College of Qatar, Doha, Qatar., Masud Danjuma M; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar.; Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Mir FA; Qatar Metabolic Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Parray A; The Neuroscience Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Yousaf Z; Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Siddiqui MYA; Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Abdelmajid A; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar., Mulhim M; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar., Al-Shokri S; Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Abukhattab M; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar., Shaheen R; Natural and Medical Sciences Research Centre, University of Nizwa, Nizwa, Oman., Elkord E; Natural and Medical Sciences Research Centre, University of Nizwa, Nizwa, Oman.; Biomedical Research Centre, School of Science, Engineering and Environment, University of Salford, Manchester, United Kingdom., Al-Khal AL; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar., Elzouki AN; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar.; Internal Medicine Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar., Girardi G; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar.; Department of Basic Medical Sciences, College of Medicine, Member of QU Health, Qatar University, Doha, Qatar.

Publikováno v: Frontiers in immunology [Front Immunol] 2021 Dec 13; Vol. 12, pp. 707159. Date of Electronic Publication: 2021 Dec 13 (Print Publication: 2021).